DUPIXENT is a prescription medicine used as an add-on maintenance treatment in adults and children 6 years of age and older who have moderate-to-severe eosinophilic or oral steroid dependent asthma that is not controlled with their current asthma medicines. DUPIXENT is not used to treat sudden breathing problems and will not replace an inhaled rescue medicine.
OCS are a treatment often prescribed to patients with Asthma, but there are potential long-term and short-term risks of repeated steroid use. Asthma management can reduce risk of OCS use for long-term management.
Oral steroids can be helpful for controlling asthma symptoms when prescribed, but using them to treat
your asthma more than twice a year could be a sign your asthma is uncontrolled. The potential short-
term and long-term risks increase with each use.
You should always speak with your doctor about the medication you’re taking.
Weight gain
Elevated eye pressure
(glaucoma)
Problems with mood, stress,
sleep, memory, and behavior
Vision loss (cataracts)
Bone loss (osteoporosis)
Diabetes
This is not a complete list of all potential risks associated with oral steroid use. For more information, speak with your healthcare provider.
Between asthma and everything else
you manage, steroid bursts can fade into
the background. Fill out our steroid
tracker to see the year at a glance and
share with your doctor.
Explore how DUPIXENT works in the lungs
and learn about the science of DUPIXENT.
Tim experienced side effects from the steroids he used to help his asthma. Learn how DUPIXENT played a role in decreasing his
reliance on steroids and improving control of his asthma symptoms. Individual results may vary.
DUPIXENT is not a steroid or inhaler. It helps block a key source of airway inflammation.
*Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
Fill out your personalized doctor discussion guide to help get the conversation started.
